Arqule (ARQL) Tops Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
Go back to Arqule (ARQL) Tops Q1 EPS by 1c
May 6, 2015 7:00 AM EDT
Conference call scheduled today at 9:00 a.m. eastern time
WOBURN, Mass.--(BUSINESS WIRE)--
ArQule, Inc. (NASDAQ: ARQL) today announced its financial results for
the first quarter of 2015.
For the quarter ended March 31, 2015, the Company reported a net loss of
$4,551,000 or $0.07 per share, compared to a net loss of $7,141,000 or
$0.11 per share, for the first quarter of 2014.
At March 31, 2015, the Company had a total of $53,581,000 in cash,
equivalents and marketable securities.
Operational Update
Enrollment in the pivotal Phase 3 METIV-HCC...
More
May 5, 2015 8:30 AM EDT
Parties to Focus on Immuno-Oncology Targets
Collaboration Provides for Target Screening Through Clinical
Development and Commercialization of Priority Compounds
Agreement Leverages Applications of Beryllium Platforms to Validate
Drug Targets and New Therapies
WOBURN, Mass.--(BUSINESS WIRE)--
ArQule, Inc. (NASDAQ: ARQL) and Beryllium Discovery Corp. today
announced a collaborative research and development agreement to identify
and unlock the therapeutic potential of small molecule compounds by
combining ArQules chemistry and drug development expertise with
Berylliums discovery platforms. The Beryllium platforms integrate... More
